Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression-Introducing a novel prognostic model for bladder cancer recurrence.

Rausch S, Hennenlotter J, Todenhöfer T, Aufderklamm S, Schwentner C, Sievert KD, Stenzl A, Gakis G.

Urol Oncol. 2014 Jun 21. pii: S1078-1439(14)00172-0. doi: 10.1016/j.urolonc.2014.05.009. [Epub ahead of print]

PMID:
24962661
[PubMed - as supplied by publisher]
2.

Differential gene expression profiling of enriched human spermatogonia after short- and long-term culture.

Conrad S, Azizi H, Hatami M, Kubista M, Bonin M, Hennenlotter J, Renninger M, Skutella T.

Biomed Res Int. 2014;2014:138350. doi: 10.1155/2014/138350. Epub 2014 Mar 12.

PMID:
24738045
[PubMed - in process]
Free PMC Article
3.

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma.

von Klot CA, Kramer MW, Peters I, Hennenlotter J, Abbas M, Scherer R, Herrmann TR, Stenzl A, Kuczyk MA, Serth J, Merseburger AS.

BMC Clin Pathol. 2014 Apr 3;14(1):15. [Epub ahead of print]

PMID:
24708743
[PubMed - as supplied by publisher]
Free PMC Article
4.

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.

Peters I, Gebauer K, Dubrowinskaja N, Atschekzei F, Kramer MW, Hennenlotter J, Tezval H, Abbas M, Scherer R, Merseburger AS, Stenzl A, Kuczyk MA, Serth J.

Oncol Rep. 2014 Apr;31(4):1523-30. doi: 10.3892/or.2014.3030. Epub 2014 Feb 18.

PMID:
24549248
[PubMed - in process]
Free PMC Article
5.

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma.

Peters I, Dubrowinskaja N, Kogosov M, Abbas M, Hennenlotter J, von Klot C, Merseburger AS, Stenzl A, Scherer R, Kuczyk MA, Serth J.

BMC Cancer. 2014 Feb 17;14:101. doi: 10.1186/1471-2407-14-101.

PMID:
24533449
[PubMed - in process]
Free PMC Article
6.

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study.

Horstmann M, Banek S, Gakis G, Todenhöfer T, Aufderklamm S, Hennenlotter J, Stenzl A, Schwentner C; UroScreen study group.

Springerplus. 2014 Jan 13;3:24. doi: 10.1186/2193-1801-3-24. eCollection 2014.

PMID:
24478941
[PubMed]
Free PMC Article
7.

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.

Dubrowinskaja N, Gebauer K, Peters I, Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS, Stenzl A, Grünwald V, Kuczyk MA, Serth J.

Cancer Med. 2014 Apr;3(2):300-9. doi: 10.1002/cam4.181. Epub 2014 Jan 27.

PMID:
24464810
[PubMed - in process]
Free PMC Article
8.

Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.

Aufderklamm S, Todenhöfer T, Hennenlotter J, Mischinger J, Böttge J, Rausch S, Halalsheh O, Stenzl A, Gakis G, Schwentner C.

J Endourol. 2014 Jun;28(6):668-74. doi: 10.1089/end.2013.0755. Epub 2014 Feb 14.

PMID:
24422683
[PubMed - in process]
9.

Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer.

Ritter R, Hennenlotter J, Kühs U, Hofmann U, Aufderklamm S, Blutbacher P, Deja A, Hohneder A, Gerber V, Gakis G, Stenzl A, Schwentner C, Todenhöfer T.

Urol Oncol. 2014 Apr;32(3):337-44. doi: 10.1016/j.urolonc.2013.09.024. Epub 2013 Dec 12.

PMID:
24332643
[PubMed - in process]
10.

Reliable housekeeping gene combination for quantitative PCR of lymph nodes in patients with prostate cancer.

Tsaur I, Renninger M, Hennenlotter J, Oppermann E, Munz M, Kuehs U, Stenzl A, Schilling D.

Anticancer Res. 2013 Dec;33(12):5243-8.

PMID:
24324056
[PubMed - indexed for MEDLINE]
11.

A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.

Grimm M, Schmitt S, Teriete P, Biegner T, Stenzl A, Hennenlotter J, Muhs HJ, Munz A, Nadtotschi T, König K, Sänger J, Feyen O, Hofmann H, Reinert S, Coy JF.

BMC Cancer. 2013 Dec 4;13:569. doi: 10.1186/1471-2407-13-569.

PMID:
24304513
[PubMed - indexed for MEDLINE]
Free Article
12.

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes.

Sittig SP, Køllgaard T, Grønbæk K, Idorn M, Hennenlotter J, Stenzl A, Gouttefangeas C, Thor Straten P.

Oncoimmunology. 2013 Sep 1;2(9):e26014. Epub 2013 Sep 26.

PMID:
24228230
[PubMed]
Free PMC Article
13.

Isolation of adult human spermatogonial progenitors using novel markers.

Harichandan A, Sivasubramaniyan K, Hennenlotter J, Schwentner C, Stenzl A, Bühring HJ.

J Mol Cell Biol. 2013 Oct;5(5):351-3. doi: 10.1093/jmcb/mjt029. Epub 2013 Aug 8. No abstract available.

PMID:
23929715
[PubMed - indexed for MEDLINE]
Free Article
14.

Circulating fibronectin controls tumor growth.

von Au A, Vasel M, Kraft S, Sens C, Hackl N, Marx A, Stroebel P, Hennenlotter J, Todenhöfer T, Stenzl A, Schott S, Sinn HP, Wetterwald A, Bermejo JL, Cecchini MG, Nakchbandi IA.

Neoplasia. 2013 Aug;15(8):925-38.

PMID:
23908593
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.

Fisel P, Kruck S, Winter S, Bedke J, Hennenlotter J, Nies AT, Scharpf M, Fend F, Stenzl A, Schwab M, Schaeffeler E.

Clin Cancer Res. 2013 Sep 15;19(18):5170-81. doi: 10.1158/1078-0432.CCR-13-1180. Epub 2013 Jul 23.

PMID:
23881922
[PubMed - in process]
16.

Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.

Petkova N, Hennenlotter J, Sobiesiak M, Todenhöfer T, Scharpf M, Stenzl A, Bühring HJ, Schwentner C.

Prostate. 2013 Oct;73(14):1576-90. doi: 10.1002/pros.22708. Epub 2013 Jul 8.

PMID:
23836489
[PubMed - indexed for MEDLINE]
17.

Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer.

Tezval H, Atschekzei F, Peters I, Waalkes S, Hennenlotter J, Stenzl A, Becker JU, Merseburger AS, Kuczyk MA, Serth J.

BMC Cancer. 2013 Apr 22;13:199. doi: 10.1186/1471-2407-13-199.

PMID:
23607589
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Influence of body mass index, surgical approach and lymphadenectomy on the development of symptomatic lymphoceles after radical prostatectomy.

Mundhenk J, Hennenlotter J, Alloussi S, Selbherr D, Martzog JC, Todenhöfer T, Kruck S, Schwentner C, Stenzl A, Schilling D.

Urol Int. 2013;90(3):270-6. doi: 10.1159/000347043. Epub 2013 Mar 14.

PMID:
23548783
[PubMed - indexed for MEDLINE]
19.

Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.

Aufderklamm S, Todenhöfer T, Hennenlotter J, Gakis G, Mischinger J, Mundhenk J, Germann M, Stenzl A, Schwentner C.

J Endourol. 2013 Jul;27(7):856-61. doi: 10.1089/end.2012.0648. Epub 2013 Jun 11.

PMID:
23516988
[PubMed - indexed for MEDLINE]
20.

[Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].

Aufderklamm S, Todenhöfer T, Hennenlotter J, Gakis G, Mischinger J, Mundhenk J, Germann M, Stenzl A, Schwentner C.

Urologe A. 2013 Aug;52(8):1097-103. doi: 10.1007/s00120-013-3133-5. German.

PMID:
23416965
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk